1 Einträge von mit treatment prophylactic
www.cslbehring.ch
Datum der Indexierung 04.10.2024 23:31:04
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D CSL R&D in Switzerland Investigator Initiated Studies We operate as one integrated global R&D organization that ass prophylactic infusions of factor IX to temporarily replace or supplement low levels of the blood-clotting factor. About HEMGENIX® HEMGENIX® is a gene therapy that reduces the rate of abnormal bleeding in eligible people with hemop
Text Inhalt Text aus URL
Log Metriken 86111
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D CSL R&D in Switzerland Investigator Initiated Studies We operate as one integrated global R&D organization that ass prophylactic infusions of factor IX to temporarily replace or supplement low levels of the blood-clotting factor. About HEMGENIX® HEMGENIX® is a gene therapy that reduces the rate of abnormal bleeding in eligible people with hemop
Text Inhalt Text aus URL
Log Metriken 86111